$HAE
HAEMONETICS CORP Stock $hae

$hae Overview Financials Valuation SEC Filings Company Website

2018 Q2 Form 10-Q Financial Statement

#000031314318000052 Filed on August 07, 2018

Income Statement

Concept	2018 Q2	2017 Q3
Revenue	$229.3M	$211.0M
YoY Change	0.56%	0.47%
Cost Of Revenue	$146.1M	$120.8M
YoY Change	0.07%	1.61%
Gross Profit	$83.24M	$104.6M
YoY Change	1.38%	14.83%
Gross Profit Margin	36.3%	49.57%
Selling, General & Admin	$68.55M	$72.78M
YoY Change	-6.23%	-16.82%
% of Gross Profit	82.34%	69.61%
Research & Development	$9.406M	$7.521M
YoY Change	1.14%	-34.24%
% of Gross Profit	11.3%	7.19%
Depreciation & Amortization	$26.40M	$21.80M
YoY Change	18.92%	-3.11%
% of Gross Profit	31.71%	20.85%
Operating Expenses	$77.95M	$80.30M
YoY Change	-5.4%	-18.83%
Operating Profit	$5.293M	$24.26M
YoY Change	-109.2%	-407.8%
Interest Expense	-$2.000M	-$1.400M
YoY Change	17.65%	-36.36%
% of Operating Profit	-37.79%	-5.77%
Other Income/Expense, Net	-$1.978M	-$1.397M
YoY Change		-35.83%
Pretax Income	$3.315M	$22.86M
YoY Change	-105.6%	-327.29%
Income Tax	$6.100M	$2.759M
% Of Pretax Income	184.01%	12.07%
Net Earnings	-$2.819M	$20.10M
YoY Change	-94.49%	-294.3%
Net Earnings / Revenue	-1.23%	9.53%
Basic Earnings Per Share	-$0.05	$0.38
Diluted Earnings Per Share	-$0.05	$0.38
COMMON SHARES
Basic Shares Outstanding	52.12M shares	52.62M shares
Diluted Shares Outstanding	52.12M shares	52.98M shares

Balance Sheet

Concept	2018 Q2	2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$192.1M	$171.7M
YoY Change	37.61%	45.26%
Cash & Equivalents	$192.1M	$203.6M
Short-Term Investments
Other Short-Term Assets	$32.20M	$31.00M
YoY Change	-21.08%	-4.02%
Inventory	$175.3M	$168.6M
Prepaid Expenses
Receivables	$151.3M	$143.7M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$551.0M	$553.4M
YoY Change	8.04%	13.03%
LONG-TERM ASSETS
Property, Plant & Equipment	$315.9M	$320.2M
YoY Change	-2.47%	-5.72%
Goodwill	$210.9M	$211.1M
YoY Change	0.03%	-21.39%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$10.87M	$12.57M
YoY Change	-12.68%	-9.22%
Total Long-Term Assets	$690.2M	$717.8M
YoY Change	-5.29%	-13.29%
TOTAL ASSETS
Total Short-Term Assets	$551.0M	$553.4M
Total Long-Term Assets	$690.2M	$717.8M
Total Assets	$1.241B	$1.271B
YoY Change	0.2%	-3.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$65.39M	$41.76M
YoY Change	52.17%	13.49%
Accrued Expenses	$45.80M	$31.90M
YoY Change	5.29%	-27.99%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$17.04M	$108.6M
YoY Change	-72.07%	132.01%
Total Short-Term Liabilities	$194.0M	$255.0M
YoY Change	-8.14%	28.16%
LONG-TERM LIABILITIES
Long-Term Debt	$330.8M	$178.0M
YoY Change	30.44%	-49.56%
Other Long-Term Liabilities	$31.67M	$23.52M
YoY Change	42.78%	-17.59%
Total Long-Term Liabilities	$362.5M	$201.5M
YoY Change	31.44%	-47.17%
TOTAL LIABILITIES
Total Short-Term Liabilities	$194.0M	$255.0M
Total Long-Term Liabilities	$362.5M	$201.5M
Total Liabilities	$556.5M	$456.5M
YoY Change	14.28%	-21.34%
SHAREHOLDERS EQUITY
Retained Earnings	$189.9M	$330.2M
YoY Change	-34.51%	7.95%
Common Stock	$507.9M	$498.5M
YoY Change	5.25%	11.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$674.1M	$801.3M
YoY Change
Total Liabilities & Shareholders Equity	$1.241B	$1.271B
YoY Change	0.2%	-3.51%

Cashflow Statement

Concept	2018 Q2	2017 Q3
OPERATING ACTIVITIES
Net Income	-$2.819M	$20.10M
YoY Change	-94.49%	-294.3%
Depreciation, Depletion And Amortization	$26.40M	$21.80M
YoY Change	18.92%	-3.11%
Cash From Operating Activities	$23.12M	$38.43M
YoY Change	-32.98%	25.18%
INVESTING ACTIVITIES
Capital Expenditures	$27.51M	$13.72M
YoY Change	-276.37%	-38.96%
Acquisitions
YoY Change
Other Investing Activities	$300.0K	$10.00M
YoY Change	-70.0%
Cash From Investing Activities	-$27.26M	-$3.740M
YoY Change	86.74%	-83.3%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$80.00M	$0.00
YoY Change
Debt Paid & Issued, Net	$253.7M	$11.86M
YoY Change		66.66%
Cash From Financing Activities	$18.66M	-$3.549M
YoY Change	-279.45%	-28.82%
NET CHANGE
Cash From Operating Activities	$23.12M	$38.43M
Cash From Investing Activities	-$27.26M	-$3.740M
Cash From Financing Activities	$18.66M	-$3.549M
Net Change In Cash	$14.52M	$31.14M
YoY Change	52.85%	838.68%
FREE CASH FLOW
Cash From Operating Activities	$23.12M	$38.43M
Capital Expenditures	$27.51M	$13.72M
Free Cash Flow	-$4.392M	$24.70M
YoY Change	-108.77%	200.68%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2018Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2018Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2018Q2	dei	Document Period End Date DocumentPeriodEndDate	2018-06-30
CY2018Q2	dei	Document Type DocumentType	10-Q
CY2018Q2	dei	Entity Central Index Key EntityCentralIndexKey	0000313143
CY2018Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	51691865	shares
CY2018Q2	dei	Amendment Flag AmendmentFlag	false
CY2018Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-30
CY2018Q2	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2018Q2	dei	Entity Registrant Name EntityRegistrantName	HAEMONETICS CORP
CY2018Q2	hae	Capitalized Software Development Costs Placedinto Service CapitalizedSoftwareDevelopmentCostsPlacedintoService	10600000	USD
CY2017Q3	hae	Effectof Exchange Rateon Revenues EffectofExchangeRateonRevenues	-2999000	USD
CY2018Q2	hae	Effectof Exchange Rateon Revenues EffectofExchangeRateonRevenues	69000	USD
CY2017Q3	hae	Effectof Exchange Rateson Operating Income EffectofExchangeRatesonOperatingIncome	-2201000	USD
CY2018Q2	hae	Effectof Exchange Rateson Operating Income EffectofExchangeRatesonOperatingIncome	3055000	USD
CY2018Q2	hae	General Warranty Period On Parts And Labor GeneralWarrantyPeriodOnPartsAndLabor	P1Y
CY2017Q3	hae	Net Revenues Before Foreign Exchange Impact NetRevenuesBeforeForeignExchangeImpact	213950000	USD
CY2018Q2	hae	Net Revenues Before Foreign Exchange Impact NetRevenuesBeforeForeignExchangeImpact	229278000	USD
CY2018Q2	hae	Restructuring Charges Payable In Next Twelve Months RestructuringChargesPayableInNextTwelveMonths	18100000	USD
CY2017Q3	hae	Restructuring Related Costs RestructuringRelatedCosts	1427000	USD
CY2018Q2	hae	Restructuring Related Costs RestructuringRelatedCosts	3641000	USD
CY2017Q3	hae	Restructuringand Restructuring Related Costs RestructuringandRestructuringRelatedCosts	2483000	USD
CY2018Q2	hae	Restructuringand Restructuring Related Costs RestructuringandRestructuringRelatedCosts	3349000	USD
CY2017Q3	hae	Restructuringand Turnaround Costs RestructuringandTurnaroundCosts	2483000	USD
CY2018Q2	hae	Restructuringand Turnaround Costs RestructuringandTurnaroundCosts	3349000	USD
CY2017Q3	hae	Transfers From Inventory To Fixed Assets TransfersFromInventoryToFixedAssets	1338000	USD
CY2018Q2	hae	Transfers From Inventory To Fixed Assets TransfersFromInventoryToFixedAssets	1799000	USD
CY2018Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	55265000	USD
CY2018Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	65393000	USD
CY2018Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	151226000	USD
CY2018Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	151336000	USD
CY2018Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-18991000	USD
CY2018Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-23710000	USD
CY2018Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	503955000	USD
CY2018Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	507394000	USD
CY2017Q3	us-gaap	Adjustment For Amortization AdjustmentForAmortization	6491000	USD
CY2018Q2	us-gaap	Adjustment For Amortization AdjustmentForAmortization	6300000	USD
CY2018Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2111000	USD
CY2018Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2327000	USD
CY2017Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	700000	shares
CY2017Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	32175000	USD
CY2018Q2	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	11937000	USD
CY2018Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	21170000	USD
CY2018Q1	us-gaap	Assets Assets	1237339000	USD
CY2018Q2	us-gaap	Assets Assets	1241168000	USD
CY2018Q1	us-gaap	Assets Current AssetsCurrent	521177000	USD
CY2018Q2	us-gaap	Assets Current AssetsCurrent	551017000	USD
CY2018Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	71800000	USD
CY2018Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	72500000	USD
CY2018Q1	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	17700000	USD
CY2018Q2	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	7800000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	139564000	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	171739000	USD
CY2018Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	180169000	USD
CY2018Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	192106000	USD
CY2018Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2018Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2018Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	52342965	shares
CY2018Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	51641159	shares
CY2018Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	52342965	shares
CY2018Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	51641159	shares
CY2018Q1	us-gaap	Common Stock Value CommonStockValue	523000	USD
CY2018Q2	us-gaap	Common Stock Value CommonStockValue	516000	USD
CY2017Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	23766000	USD
CY2018Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7538000	USD
CY2018Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	4000000	USD
CY2018Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	2700000	USD
CY2018Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	17300000	USD
CY2018Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	16600000	USD
CY2018Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	7400000	USD
CY2017Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	119286000	USD
CY2018Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	146103000	USD
CY2018Q1	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	3961000	USD
CY2018Q2	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	3774000	USD
CY2018Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	6526000	USD
CY2018Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	10606000	USD
CY2017Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	21789000	USD
CY2018Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	26415000	USD
CY2017Q3	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	8000000	USD
CY2018Q2	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	0	USD
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.38
CY2018Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2017Q3	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	1039000	USD
CY2018Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.38
CY2018Q2	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-2584000	USD
CY2018Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	1.85
CY2018Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	69519000	USD
CY2018Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	45828000	USD
CY2017Q3	us-gaap	Employee Stock Ownership Plan Esop Cash Contributions To Esop EmployeeStockOwnershipPlanESOPCashContributionsToESOP	1622000	USD
CY2018Q2	us-gaap	Employee Stock Ownership Plan Esop Cash Contributions To Esop EmployeeStockOwnershipPlanESOPCashContributionsToESOP	1780000	USD
CY2018Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	249278000	USD
CY2018Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	256675000	USD
CY2018Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	156589000	USD
CY2018Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	148730000	USD
CY2018Q1	us-gaap	Goodwill Goodwill	211395000	USD
CY2018Q2	us-gaap	Goodwill Goodwill	210903000	USD
CY2017Q3	us-gaap	Gross Profit GrossProfit	91665000	USD
CY2018Q2	us-gaap	Gross Profit GrossProfit	83244000	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	23252000	USD
CY2018Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	3315000	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3115000	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3100000	USD
CY2018Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6134000	USD
CY2018Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6100000	USD
CY2017Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2151000	USD
CY2018Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1817000	USD
CY2017Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-11865000	USD
CY2018Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-6913000	USD
CY2017Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2203000	USD
CY2018Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1577000	USD
CY2017Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1417000	USD
CY2018Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	15058000	USD
CY2017Q3	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-8998000	USD
CY2018Q2	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	1214000	USD
CY2017Q3	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	-817000	USD
CY2018Q2	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	-72000	USD
CY2017Q3	us-gaap	Interest Paid Net InterestPaidNet	1825000	USD
CY2018Q2	us-gaap	Interest Paid Net InterestPaidNet	2361000	USD
CY2018Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	97028000	USD
CY2018Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	113418000	USD
CY2018Q1	us-gaap	Inventory Net InventoryNet	160799000	USD
CY2018Q2	us-gaap	Inventory Net InventoryNet	175329000	USD
CY2018Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	52997000	USD
CY2018Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	49437000	USD
CY2018Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	10774000	USD
CY2018Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	12474000	USD
CY2017Q3	us-gaap	Legal Fees LegalFees	0	USD
CY2018Q2	us-gaap	Legal Fees LegalFees	675000	USD
CY2018Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1237339000	USD
CY2018Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1241168000	USD
CY2018Q1	us-gaap	Liabilities Current LiabilitiesCurrent	384703000	USD
CY2018Q2	us-gaap	Liabilities Current LiabilitiesCurrent	193995000	USD
CY2018Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	194259000	USD
CY2018Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	17043000	USD
CY2018Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	59423000	USD
CY2018Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	330838000	USD
CY2017Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3549000	USD
CY2018Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	18663000	USD
CY2017Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3740000	USD
CY2018Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-27264000	USD
CY2017Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	38425000	USD
CY2018Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	23122000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	20137000	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	-2819000	USD
CY2018Q2	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	unit
CY2017Q3	us-gaap	Operating Expenses OperatingExpenses	75054000	USD
CY2018Q2	us-gaap	Operating Expenses OperatingExpenses	77951000	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	16611000	USD
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	5293000	USD
CY2017Q3	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	0	USD
CY2018Q2	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	21170000	USD
CY2018Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	12061000	USD
CY2018Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10871000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-5577000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4719000	USD
CY2018Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	65660000	USD
CY2018Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	65731000	USD
CY2018Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	34258000	USD
CY2018Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	31670000	USD
CY2017Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1359000	USD
CY2018Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1978000	USD
CY2017Q3	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	658000	USD
CY2018Q2	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	19000	USD
CY2017Q3	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2018Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	80000000	USD
CY2018Q2	us-gaap	Payments For Restructuring PaymentsForRestructuring	7850000	USD
CY2017Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	13721000	USD
CY2018Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	27514000	USD
CY2018Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	28983000	USD
CY2018Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	32246000	USD
CY2017Q3	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	9000000	USD
CY2018Q2	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	USD
CY2017Q3	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	241000	USD
CY2018Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2831000	USD
CY2017Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	176000	USD
CY2017Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	377000	USD
CY2018Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	316000	USD
CY2018Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	275000	USD
CY2017Q3	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	0	USD
CY2018Q2	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	347780000	USD
CY2017Q3	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	255000	USD
CY2018Q2	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	0	USD
CY2017Q3	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	981000	USD
CY2018Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	250000	USD
CY2017Q3	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	6430000	USD
CY2018Q2	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	198000	USD
CY2017Q3	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	442000	USD
CY2018Q2	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	157000	USD
CY2018Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	332156000	USD
CY2018Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	315873000	USD
CY2017Q3	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	928000	USD
CY2018Q2	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	-352000	USD
CY2018Q2	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-858000	USD
CY2017Q3	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	11856000	USD
CY2018Q2	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	253728000	USD
CY2017Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8193000	USD
CY2018Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9406000	USD
CY2017Q3	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	3100000	USD
CY2018Q2	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	700000	USD
CY2017Q3	us-gaap	Restructuring Charges RestructuringCharges	1056000	USD
CY2018Q2	us-gaap	Restructuring Charges RestructuringCharges	-292000	USD
CY2018Q1	us-gaap	Restructuring Reserve RestructuringReserve	28535000	USD
CY2018Q2	us-gaap	Restructuring Reserve RestructuringReserve	20256000	USD
CY2017Q3	us-gaap	Restructuring Reserve Accelerated Depreciation RestructuringReserveAcceleratedDepreciation	0	USD
CY2018Q2	us-gaap	Restructuring Reserve Accelerated Depreciation RestructuringReserveAcceleratedDepreciation	3939000	USD
CY2018Q2	us-gaap	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	-137000	USD
CY2018Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	266942000	USD
CY2018Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	189859000	USD
CY2017Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	210951000	USD
CY2018Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	229347000	USD
CY2018Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	19800000	USD
CY2018Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2018Q2	us-gaap	Revenue Remaining Performance Obligation Optional Exemption Remaining Duration RevenueRemainingPerformanceObligationOptionalExemptionRemainingDuration	P1Y
CY2018Q2	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.56
CY2017Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	66861000	USD
CY2018Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	68545000	USD
CY2017Q3	us-gaap	Share Based Compensation ShareBasedCompensation	1343000	USD
CY2018Q2	us-gaap	Share Based Compensation ShareBasedCompensation	3379000	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	752429000	USD
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	674059000	USD
CY2017Q3	us-gaap	Tax Adjustments Settlements And Unusual Provisions TaxAdjustmentsSettlementsAndUnusualProvisions	400000	USD
CY2018Q2	us-gaap	Tax Adjustments Settlements And Unusual Provisions TaxAdjustmentsSettlementsAndUnusualProvisions	-1400000	USD
CY2017Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	368000	shares
CY2018Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2017Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	52811000	shares
CY2018Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	52119000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	52443000	shares
CY2018Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	52119000	shares

Files In Submission

Name	View Source	Status
0000313143-18-000052-index-headers.html	Edgar Link	pending
0000313143-18-000052-index.html	Edgar Link	pending
0000313143-18-000052.txt	Edgar Link	pending
0000313143-18-000052-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
hae-20180630.xml	Edgar Link	completed
hae-20180630.xsd	Edgar Link	pending
hae-20180630_cal.xml	Edgar Link	unprocessable
hae-20180630_def.xml	Edgar Link	unprocessable
hae-20180630_lab.xml	Edgar Link	unprocessable
hae-20180630_pre.xml	Edgar Link	unprocessable
haeq1jun2019doc.htm	Edgar Link	pending
haeq1jun2019ex102.htm	Edgar Link	pending
haeq1jun2019ex103.htm	Edgar Link	pending
haeq1jun2019ex104.htm	Edgar Link	pending
haeq1jun2019ex105.htm	Edgar Link	pending
haeq1jun2019ex311.htm	Edgar Link	pending
haeq1jun2019ex312.htm	Edgar Link	pending
haeq1jun2019ex321.htm	Edgar Link	pending
haeq1jun2019ex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HAE
HAEMONETICS CORP Stock $hae

2018 Q2 Form 10-Q Financial Statement

#000031314318000052 Filed on August 07, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HAE HAEMONETICS CORP Stock $hae

2018 Q2 Form 10-Q Financial Statement

#000031314318000052 Filed on August 07, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HAE
HAEMONETICS CORP Stock $hae